Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “extracellular”

61 pharma patents match "extracellular" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 61
Index total 30,257
Page 2 / 3

Quick answer

This filtered view shows 61 pharmaceutical patents matching "extracellular" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

61 results for “extracellular” · 30,257 patents in full index Clear search

  1. US 10251977

    Compositions and methods for tissue repair with extracellular matrices

    The Regents of the University of California · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted
  2. US 9623051

    Decellularized extracellular matrix

    The Regents of the University of California · Granted Apr 18, 2017 · Expires Apr 13, 2037

    granted
  3. US 9592256

    Compositions and methods for tissue repair with extracellular matrices

    The Regents of the University of California · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted
  4. US 9566314

    Extracellular vesicles comprising recombinant lysosomal transmembrane protein

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Feb 14, 2017 · Expires Feb 9, 2037

    granted
  5. US 9415105

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 16, 2016 · Expires Aug 11, 2036

    granted
  6. US 9347951

    Fusion protein comprising the extracellular domain of a filovirus glycoprotein fused to an immunoglobulin heavy chain constant region

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted May 24, 2016 · Expires May 19, 2036

    granted
  7. US 9274109

    Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same

    Aeon Medix Inc. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted
  8. US 9201072

    Gut flora-derived extracellular vesicles, and method for searching for a disease model, vaccine, and candidate drug and for diagnosis using the same

    Aeon Medix Inc. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted
  9. US 9175065

    FGFR extracellular domain acidic region muteins

    Five Prime Therapeutics, Inc. · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted
  10. US 8992930

    Extracellular IFI16 as therapeutic agents

    University of Piemonte Orientale · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted
  11. US 8969653

    Extracellular vesicles derived from gram-positive bacteria, and use thereof

    Aeon Medix Inc. · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  12. US 8951972

    FGFR1 extracellular domain combination therapies for lung cancer

    Five Prime Therapeutics, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted
  13. US 8920799

    Methods of treating cancer by administering an Axl ligand-binding portion of an Axl tyrosine kinase receptor extracellular domain

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 30, 2014 · Expires Dec 25, 2034

    granted
  14. US 8835166

    Extracellular matrix material created using non-thermal irreversible electroporation

    The Regents of the University of California · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted
  15. US 8728488

    Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, CENTERS FOR DISEASE CONTROL AND PREVENTION · Granted May 20, 2014 · Expires May 15, 2034

    granted
  16. US 8716301

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034

    granted
  17. US 8691522

    Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof

    Aeon Medix Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  18. US 8685931

    Hair growth methods using FGFR3 extracellular domains

    Five Prime Therapeutics, Inc. · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted
  19. US 8445445

    Method of promoting hair growth using FGFR4 extracellular domains

    Five Prime Therapeutics, Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  20. US 8431532

    FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same

    Five Prime Therapeutics, Inc. · Granted Apr 30, 2013 · Expires Apr 25, 2033

    granted
  21. US 8399609

    Treating or preventing extracellular matrix build-up

    REGENERX BIOPHARMACEUTICALS, INC. · Granted Mar 19, 2013 · Expires Mar 14, 2033

    granted
  22. US 8383102

    Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  23. US 8338569

    FGFR extracellular domain acidic region muteins

    Five Prime Therapeutics, Inc. · Granted Dec 25, 2012 · Expires Dec 20, 2032

    granted
  24. US 8282926

    CCR5-specific antibodies with HIV neutralizing activity that recognize a linear dodecapeptide that mimics a conformational epitope in the second extracellular loop of CCR5

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted